Dorman Products, Inc. (DORM) Stock Price & Analysis
Dorman Products, Inc. (DORM) closed at USD 127.49 on Thursday, October 22, 2026, up 3.34% on the day. The US market is currently closed (pre-market); this is not a live price.
The prior close was USD 123.37; the Oct 22, 2026 session ranged USD 123.39–127.57 on volume of 162,645 shares. Market capitalization is $3.78B, with a 52-week range of USD 98.45–164 (NMS). Source: Nexqual, retrieved October 23, 2026 at 09:27 UTC.
Also available as compact Markdown for AI agents: nexqual.com/DORM.md
Key facts (DORM)
- Last four reported quarters (through Jun 27, 2026): revenue $2.16B, net income $219M (10.2% margin), free cash flow $214M (SEC filings).
- Valuation: P/E 17.3x (avg 20.0x at the last 3 fiscal year-ends), EV/EBITDA 11.1x, net debt $308M.
- 1 of 80 tracked superinvestors hold DORM (13F, Q2 2026): 0 new, 1 added, 0 reduced, 0 unchanged.
- Analysts: Buy (mean 1.88 on a 1–5 scale) (8 analysts), mean target USD 161.63 (range 154–170).
- Total return with dividends: 1Y -17.9% vs S&P 500 +14.9%; 5Y +24.6% vs S&P 500 +80.3%.
- Next earnings: 2026-10-26, EPS estimate USD 2, revenue estimate $565M.
Financials (SEC 10-K; TTM = last four 10-Q/10-K quarters) (DORM)
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | TTM |
|---|---|---|---|---|---|---|
| Revenue | $1.35B | $1.73B | $1.93B | $2.01B | $2.13B | $2.16B |
| Gross profit | $463M | $564M | $685M | $806M | $898M | — |
| Operating income | $172M | $171M | $215M | $293M | $300M | $312M |
| Net income | $132M | $122M | $129M | $190M | $204M | $219M |
| EPS (diluted) | $4.12 | $3.85 | $4.10 | $6.14 | $6.64 | — |
| Free cash flow | $80.5M | $3.8M | $165M | $192M | $75.7M | $214M |
| Gross margin | 34.4% | 32.6% | 35.5% | 40.1% | 42.1% | — |
| Operating margin | 12.8% | 9.9% | 11.1% | 14.6% | 14.1% | 14.5% |
| Net margin | 9.8% | 7.0% | 6.7% | 9.5% | 9.6% | 10.2% |
| Revenue growth | +23.1% | +28.9% | +11.3% | +4.1% | +6.0% | — |
| Cash + short-term investments | $58.8M | $46.0M | $36.8M | $57.1M | $49.4M | — |
| Total debt | $0K | $495M | $483M | $469M | $441M | — |
Fiscal years end Dec. EPS is split-adjusted.
Valuation (price ÷ last four quarters, through Jun 27, 2026) (DORM)
P/E 17.3x · P/S 1.8x · EV/EBITDA 11.1x · EV/Sales 1.9x · P/FCF 17.7x · P/B 2.5x · FCF yield 5.66% · Earnings yield 5.80% · Net debt $308M · EV $4.09B
P/E at fiscal year-ends: Dec 2025 18.6x, Dec 2024 21.1x, Dec 2023 20.3x.
Superinvestors (SEC 13F-HR, Q2 2026) (DORM)
1 of 80 tracked investors hold DORM. Each row is the investor's latest 13F; change is vs their prior-quarter share count.
| Investor | Firm | % of portfolio | Value | Change |
|---|---|---|---|---|
| First Eagle Investment | First Eagle Investment Management | 0.04% | $21.6M | Added +73.7% |
Analysts (DORM)
Consensus Buy (mean 1.88 on a 1–5 scale), 8 analysts; mean target USD 161.63 (low 154, high 170).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-08-05 | Wells Fargo | Target raised | Overweight | $155 → $160 |
| 2026-07-21 | Wells Fargo | Target raised | Overweight | $140 → $155 |
Total return (dividends reinvested) (DORM)
| 1Y (from 2025-10-23) | 5Y (from 2021-10-18) | |
|---|---|---|
| Total return | -17.9% | +24.6% |
| S&P 500 (SPY) | +14.9% | +80.3% |
| Per year | -17.9% | +4.5% |
| Volatility (annualized) | 36.0% | 31.5% |
| Max drawdown | -36.4% (Oct 2025→Apr 2026) | -43.3% (Nov 2021→Nov 2023) |
DORM analyst estimates and revisions
| Period | EPS estimate | 90 days ago | Change | Revenue estimate | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends Sep 2026) | $2.00 | $2.35 | -15.1% | $565.3M | 8 |
| Next quarter (ends Dec 2026) | $2.02 | $2.47 | -18.2% | $570.2M | 8 |
| Current fiscal year (ends Dec 2026) | $8.66 | $8.28 | +4.7% | $2.21B | 8 |
| Next fiscal year (ends Dec 2027) | $9.20 | $9.37 | -1.9% | $2.32B | 8 |
Key Statistics (as of October 23, 2026 at 09:27 UTC)
| Price | USD 127.49 |
|---|---|
| Change | ▲ 3.34% (up) |
| Previous Close | USD 123.37 |
| Open | USD 123.39 |
| Day Range | USD 123.39 – 127.57 |
| 52-Week Range | USD 98.45 – 164 |
| Volume | 162,645 shares |
| Market Cap | $3.78B |
| Exchange | NMS |
Technical Analysis (DORM)
Nexqual's technical model rates DORM "NEUTRAL" based on 4 bullish and 3 bearish signals across 127 daily candles, as of October 23, 2026 at 09:27 UTC.
| Overall Signal | NEUTRAL |
|---|---|
| RSI (14) | 55.68 (neutral) |
| vs SMA50 | Above (USD 126.19) |
| MACD | -0.42 (negative) |
Analyst Ratings (DORM)
Wall Street analysts rate DORM "Buy" based on 8 analysts, with a mean price target of USD 161.63 (range USD 154–170), per Nexqual as of October 23, 2026 at 09:27 UTC.
| Consensus Rating | Buy |
|---|---|
| Analyst Count | 8 |
| Mean Target | USD 161.63 |
| High Target | USD 170 |
| Low Target | USD 154 |
| Buy / Hold / Sell | 7 / 1 / 0 |
Earnings (DORM)
| Next Earnings Date | 2026-10-26 |
|---|---|
| EPS Estimate | USD 2 |
| Revenue Estimate | $565.34M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-06-30 | USD 3.08 vs est 1.89 ▲ beat |
| 2026-03-31 | USD 1.57 vs est 1.56 ▲ beat |
| 2025-12-31 | USD 2.17 vs est 2.12 ▲ beat |
| 2025-09-30 | USD 2.62 vs est 2.5 ▲ beat |
Source: Nexqual, October 23, 2026 at 09:27 UTC.
Financials & Fundamentals (DORM)
| Total Revenue | $2.16B |
|---|---|
| Revenue Growth (latest quarter, YoY) | +0.70% |
| Gross Margin | +42.31% |
| Operating Margin | +23.63% |
| Profit Margin | +10.18% |
| ROE | +15.05% |
| Debt / Equity | 0.35 |
| Current Ratio | 3.6 |
| Total Cash | $131.98M |
| Total Debt | $528.25M |
| Free Cash Flow (last four quarters to Jun 2026, SEC 10-Q / 10-K) | $214.17M (9.9% of revenue) |
Source: Nexqual, October 23, 2026 at 09:27 UTC.
Financial Health Score (DORM)
Nexqual rates Dorman Products, Inc.'s overall financial health "Solid" across five dimensions, as of October 23, 2026 at 09:27 UTC.
| Growth | Solid — Revenue +6% YoY (annual) |
|---|---|
| Profitability | Strong — Gross margin 42%, operating 24% (last 12 months) |
| Balance Sheet | Strong — $132M cash and investments vs $440M debt (Jun 2026, SEC) |
| Cash Flow | Solid — FCF $214M (last 4 quarters to Jun 2026, SEC), 10% margin |
| Efficiency | Solid — ROE 15%, ROA 9.2% |
Ownership (DORM)
| Insider Ownership | +12.87% |
|---|---|
| Institutional Ownership | +99.30% |
| Shares Outstanding | 29.68M |
| Float | 26.11M |
| Short % of Float | +8.09% |
Source: Nexqual, October 23, 2026 at 09:27 UTC.
Leadership (DORM)
Dorman Products, Inc. is led by Kevin M. Olsen C.P.A., Chairman, President & CEO, per Nexqual as of October 23, 2026 at 09:27 UTC.
| Chairman, President & CEO | Kevin M. Olsen C.P.A. |
|---|---|
| Founder & Director | Steven L. Berman |
| Senior Vice President of Enterprise Sales | Jeffrey L. Darby |
| President of Light Duty | Eric B. Luftig |
| Senior VP & Chief Financial Officer | Charles W. Rayfield |
Major Backers & Investors (DORM)
Notable institutional backers of Dorman Products, Inc. include Morgan Stanley, Ktf Investments, LLC, Royce & Associates LP, according to Nexqual as of October 23, 2026 at 09:27 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Morgan Stanley | 4.87% |
| Ktf Investments, LLC | 2.94% |
| Royce & Associates LP | 2.78% |
| Jennison Associates LLC | 2.75% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| BlackRock | 13.74% |
| Vanguard Group | 9.25% |
| State Street | 3.85% |
| Dimensional Fund Advisors | 3.83% |
| Geode Capital | 2.51% |
| Columbia Threadneedle | 1.16% |
Source: Nexqual, October 23, 2026 at 09:27 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| ATMU | Atmus Filtration Technologies I | USD 44.75 | ▼ 0.73% |
| GNTX | Gentex Corporation | USD 21.74 | ▲ 3.52% |
| GTX | Garrett Motion Inc. | USD 22 | ▼ 8.07% |
| LKQ | LKQ Corporation | USD 22.47 | ▲ 5.1% |
| LEA | Lear Corporation | USD 118.61 | ▲ 0.61% |
| MBLY | Mobileye Global Inc. | USD 6.95 | ▼ 1% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 23, 2026 at 09:27 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt